BTA
Click for more information
0.00% 57.0¢ biota holdings limited

cost benefit analysis - iv antivirals

  1. outawater
    886 Posts.
    lightbulb Created with Sketch. 1
    clock Created with Sketch.
    24/01/11
    12:39
    Post #: 7781664
    Interesting research - Peramivir used as the test case - looks to me that Govts will not pay over the odds for any IV antivirals.

    http://www.ajmc.com/media/pdf/AJMC_11jan_Lee_WebX_e1_to_e9.pdf


    Also, is the latest GSK iv study a red herring as they already have a belated study under way ?
    BTA Price at posting: $1.18 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NIM Nimy to raise $1.21M to explore 'newsy' WA targets
right-arrow Created with Sketch.
IVR Investigator Resources hits 8m @ 1.06% copper on-site Stuart Shelf JV project acreage
right-arrow Created with Sketch.
NEWS AI stocks: What to expect in 2024-25
right-arrow Created with Sketch.
ENR Encounter sniffs 4% niobium across 1.6km of strike in WA
right-arrow Created with Sketch.
MEU Marmota hopes to punch through the ceiling of a high-grade system at Goolagong – geology willing
right-arrow Created with Sketch.
BHP BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.